Literature DB >> 24126686

Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder.

Johan Reutfors1, Lena Brandt, Olof Stephansson, Helle Kieler, Morten Andersen, Robert Bodén.   

Abstract

OBJECTIVE: Assessment of factors influencing antipsychotic prescription fills in the early phase of schizophrenia or schizoaffective disorder.
METHODS: We used the Swedish Patient Register to identify patients younger than 45 years with a first hospitalization for schizophrenia or schizoaffective disorder between 2006 and 2007 (904 patients). Data on medication were obtained from the Prescribed Drug Register. Filling a prescription of an antipsychotic drug after discharge was used to estimate medication adherence. In Cox regression models, we studied sex, country of birth, metropolitan residence, educational level, age, duration of hospitalization, history of substance use disorder, and previous use of antipsychotic drugs as predictors for antipsychotic fills.
RESULTS: Among all patients, 53.1% (95% confidence interval [CI] 49.9%-56.4%) had filled an antipsychotic prescription within 1 week from discharge. After 6 months, the proportion had increased to 80.2% (95% CI, 77.4%-82.8%) with no further increase thereafter. Prescription filling of an antipsychotic drug was primarily associated with antipsychotic use before the hospitalization (hazard ratio, 1.64; 95% CI, 1.33-2.03; for patients with access to antipsychotic drugs at admission compared with no previous use) and with longer hospitalization (hazard ratio, 1.60; 95% CI, 1.27-2.02 for 15-28 days compared with shorter hospitalization).
CONCLUSIONS: Among patients who filled a prescription of an antipsychotic drug after discharge, the majority did so within 1 week. Previous adherent use of antipsychotic drugs and longer hospitalization may be predictors of primary adherence to antipsychotic drug treatment in schizophrenia or schizoaffective disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126686     DOI: 10.1097/JCP.0b013e3182a1cd2e

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  5 in total

1.  Service Use Following First-Episode Schizophrenia Among Commercially Insured Youth.

Authors:  Todd P Gilmer; Els van der Ven; Ezra Susser; Lisa B Dixon; Mark Olfson
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

2.  Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit.

Authors:  Jenna L Gilbert; Leigh Anne Nelson; Carrie R Kriz; Yifei Liu; Courtney A Iuppa; Lauren A Diefenderfer; Ellie S R Elliott; Roger W Sommi
Journal:  Psychopharmacol Bull       Date:  2019-06-20

Review 3.  Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review.

Authors:  Saínza García; Mónica Martínez-Cengotitabengoa; Saioa López-Zurbano; Iñaki Zorrilla; Purificación López; Eduard Vieta; Ana González-Pinto
Journal:  J Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.153

4.  Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study.

Authors:  Heshu Abdullah-Koolmees; Helga Gardarsdottir; Lotte A Minnema; Kamjar Elmi; Lennart J Stoker; Judith Vuyk; Laurette E Goedhard; Toine C G Egberts; Eibert R Heerdink
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-16

5.  The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders.

Authors:  H Abdullah-Koolmees; S Nawzad; T C G Egberts; J Vuyk; H Gardarsdottir; E R Heerdink
Journal:  Ther Adv Psychopharmacol       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.